Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.
Bruker now extends their complete biology approach to mouse research by announcing development of the CosMx Mouse Whole Transcriptome (WTX) assay. The mouse WTX assay will be available for both FFPE ...
The global spatial biology market is projected to grow at a compound annual growth rate (CAGR) of approximately 15% over the next five years. Key factors fueling this growth include the rising ...
Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...
Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...
CHC Navigation (CHCNAV) announced the RS7, a new handheld SLAM (Simultaneous Localization and Mapping) scanning solution, unveiled at the 2026 CHCNAV Connect Partner Conference. Built for BIM ...
SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today announced ...
Are you attending the ABRF Annual Meeting 2026? Here are the breakout sessions and workshops you won’t want to miss.
Students, young professionals, and industry leaders invited to explore emerging GIS trends and network with innovators ...
Researchers from the National University of Singapore (NUS) have developed CellScope, a high-performance single-cell analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results